Dynamic Decoration of DNA Scaffolds for High‐Resolution Cancer Cell Subtyping

Ke Sun, Jie Xie, Xinlin Guo, Liangting Wang, Zhengheng Yu, Xiaopei Qiu, Heng Li, Kan Wang, Xiaoxing Wang, Mingxuan Song, Junsong Guo, Wei Gu, Sergio Bernardini, Chaoyong Yang, Hong Zhang, Yang LuoAdvanced 2026 · DOI

TL;DR

This paper introduces a novel DNA scaffold-based imaging platform that dynamically decorates cancer cell surfaces with fluorescent labels. By leveraging DNA logic gates and robust scaffold structures, the system achieves high-resolution, long-duration imaging and accurate subtyping of cancer cells, even at very low abundances in blood samples, paving the way for improved precision medicine.

What Problem Does This Paper Address?

Precise identification and subtyping of cancer cells are crucial for developing effective precision medicine strategies. Current methods, like immunofluorescence and flow cytometry, often struggle with low-abundance cancer cells amidst a complex cellular environment. A major limitation is the cellular internalization of fluorescent labels, which degrades imaging resolution and limits the duration of observation. This issue is exacerbated by the inherent heterogeneity of cancer cells, necessitating the simultaneous analysis of multiple membrane proteins to accurately identify distinct subtypes. The paper aims to overcome these challenges by developing a sensitive, multiplexed, and robust imaging technique for high-resolution cancer cell subtyping.

Methods

The core innovation lies in a dynamic decorating strategy using DNA scaffolds. Two primary modes were developed:

  • Self-Driven Assembly (SDA): DNA tiles, initially in a blocked state, are triggered by input strands (aptamers recognizing specific membrane proteins) to self-assemble into a DNA scaffold on the cell surface. This mode is designed for enhanced fidelity.
  • Self-Driven Disassembly (SDD): Pre-assembled DNA scaffolds are designed to disassemble upon the introduction of specific input strands, releasing fluorescent signals. This mode is optimized for expedited response times.

Both SDA and SDD leverage toehold-mediated strand displacement (TMSD) for precise molecular operations. The system incorporates molecular circuits to amplify signals and enable complex Boolean logic operations (AND, OR, NOT, NOR). For cell imaging, aptamers are used as recognition probes, binding to specific membrane proteins and initiating either the assembly or disassembly of the DNA scaffolds. The DNA scaffolds themselves are designed to be rigid and high-aspect-ratio, which significantly mitigates cellular internalization, allowing for prolonged imaging (up to 300 minutes).

Datasets

Not discussed in the paper. The study primarily uses synthetic nucleic acid inputs and various cancer cell lines (CEM, Jurkat, Ramos, K562, MCF-10A, MCF-7, MDA-MB-468, HepG2, Hela) for validation. Clinical blood samples were also used in a simulated setting.

Key Insights and Ideas

  • Robust DNA Scaffolds for Anti-Internalization: The rigid, hollow structure of the DNA scaffolds is a key innovation, effectively preventing cellular internalization and enabling long-duration imaging without signal degradation. This directly addresses a major limitation of previous fluorescent labeling techniques.
  • Dynamic Logic Gates on Cell Surfaces: The ability to perform Boolean logic operations directly on the cell membrane, triggered by specific aptamer-receptor interactions, allows for sophisticated and multiplexed identification of cancer cell subtypes.
  • Signal Amplification for Low-Abundance Detection: The integrated molecular circuits provide signal amplification, making the assay sensitive enough to detect very low concentrations of target molecules and cancer cells.
  • Tunable SDA and SDD Modes: The development of two distinct modes (SDA for fidelity, SDD for speed) offers flexibility in application, allowing researchers to choose the optimal strategy based on their specific needs.
  • High-Resolution and High-Fidelity Subtyping: The combination of robust scaffolds, precise logic operations, and signal amplification leads to highly accurate and high-resolution subtyping of cancer cells, even in complex mixtures and clinical samples.

Key Results

  • Detection Limit: The SDA mode achieved a detection limit of 27.7 pM for input A and 36.1 pM for input B, with signal amplification significantly improving sensitivity compared to systems without molecular circuits.
  • Long-Duration Imaging: DNA scaffolds prevented cellular internalization for up to 300 minutes, maintaining stable fluorescence signals at the cell membrane.
  • Leukemia Cell Subtyping (SDA-DRI): The assay could distinguish between four distinct leukemia cell subtypes in mixtures and detect cancer cells at abundances as low as 0.1% in simulated blood samples, achieving recognition efficiencies exceeding 60%.
  • Breast Cancer Cell Subtyping (SDD-TRI): The SDD-TRI system enabled rapid (within 20 minutes) and high-fidelity subtyping of five different cell lines based on their membrane protein expression profiles.
  • Comparison to Existing Methods: Apt-Tile (the proposed method) showed significantly higher signal intensity and resolution compared to Apt-Probe and Apt-HCR in cell identification assays.

Limitations and Future Work

  • Clinical Translation Challenges: The authors acknowledge that further validation is needed for actual patient samples, as confounding factors present in real clinical settings have not yet been fully addressed.
  • Standardization and Scalability: The standardization and scalable production of DNA components for consistent clinical-grade use require further development.
  • Broader Biomarker Profiling: While the platform is modular and can accommodate swappable aptamers, expanding the range of detectable membrane biomarkers and integrating more complex logic operations for even finer subtyping are potential future directions.
  • Intraoperative Guidance: The authors suggest that the programmable nanotechnology could be extended for applications in intraoperative guidance.

Summary updated

Abstract

Precise imaging of cancer cells serves as the foundation for subtype analysis, significantly advancing the development of precision medicine. The unavoidable cellular internalization of fluorescent labels constrains the resolution and timeliness, presenting a significant obstacle. This study introduces a dynamic decorating strategy of DNA scaffolds that enables the execution of four distinct Boolean logic operations through self-assembly and self-disassembly. By integrating the in-built molecular circuit, the proposed assay achieved signal-amplified detection of low-abundance nucleic acid inputs. In the application of cell imaging, inputs were labeled with aptamers to operate membrane-confined self-assembly or self-disassembly of DNA scaffolds on the cell surface, enabling simultaneous identification of distinct subtypes of cancer cells with high fidelity. The intrinsic durability of DNA scaffolds successfully prevented cellular internalization for up to 300 min, boosting the long-duration imaging. Moreover, the assay was capable of profiling a broad spectrum of cancer cell abundances from as low as 0.1% to 10% in clinical blood samples, consistently achieving recognition efficiency exceeding 60%. These findings underscore the transformational potential of DNA scaffold-based imaging tools in biological research and precision medicine.
BibTeX
@inproceedings{sun2026dynamic,
  author = {Ke Sun and Jie Xie and Xinlin Guo and Liangting Wang and Zhengheng Yu and Xiaopei Qiu and Heng Li and Kan Wang and Xiaoxing Wang and Mingxuan Song and Junsong Guo and Wei Gu and Sergio Bernardini and Chaoyong Yang and Hong Zhang and Yang Luo},
  title = {{Dynamic Decoration of DNA Scaffolds for High‐Resolution Cancer Cell Subtyping}},
  booktitle = {Advanced},
  year = {2026},
  doi = {10.1002/advs.202518307},
}

Loading related content...

Figure